Real-time collaboration in StarDrop 8
See how StarDrop integrates powerful real-time collaboration into every stage of the molecule design and optimisation workflow. This ensures your…
In this webinar join Ed Champness as he describes how a safe and efficacious drug must possess a balance of potency with appropriate ADME and toxicity properties.
The ideal property profile will be different for every project, depending on the therapeutic indication, intended route of administration and commercial factors; the goal of a drug discovery project is to target compounds that are likely to achieve this delicate balance as quickly as possible.
We will discuss how you can achieve this in practice using Optibrium’s StarDrop platform, illustrated with case studies and interactive examples.
Meet the speaker
Ed Champness
CSO, Optibrium
More resources
Connect ChemAIRS with StarDrop
Version This script is for the latest version of StarDrop for either Windows or Mac. To find out which version you have…
Fraction unbound calculation script for StarDrop
This StarDrop script estimates free fraction (fᵤ) in microsomes, hepatocytes, and plasma from experimental data in other media, experimental logD…
